Literature DB >> 14669830

Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women.

M H Gannagé-Yared1, M Azoury, I Mansour, R Baddoura, G Halaby, R Naaman.   

Abstract

In vitro studies have shown that 1,25 dihydroxyvitamin D3 [1,25(OH)2D3] decreases cytokine production by monocytes and lymphocytes. In addition, intravenous or oral pulse calcitriol treatment suppresses interleukin 6 (IL6) and interleukin1beta (IL1beta) in hemodialysis patients. We studied the effect of a daily 12-week course of 1000 mg calcium and 800 U cholecalciferol on circulating 25 hydroxyvitamin D [25(OH)D], PTH, cytokines, osteoprotegerin (OPG), C-reactive protein (CRP), bone markers, lipid parameters and insulin levels in 47 healthy post-menopausal women. Thirty-nine women completed the study. A significant increase in 25(OH)D and a significant decrease in PTH were observed (p=0.0043 and p<0.0001, respectively). In addition, alkaline phosphatase, osteocalcin and, to a lesser extent, urinary free deoxypiridinoline (DPD) decreased significantly (p<0.0001, p=0.0002 and p=0.026, respectively). No change in circulating IL6, tumor necrosis factor alpha (TNFalpha), CRP, OPG, triglycerides, LDL- and HDL-cholesterol, and insulin levels was observed. Correlation studies in the 47 women enrolled in the study revealed inverse significant correlations between OPG on one side and body mass index, LDL-cholesterol, IL6, CRP and insulin levels on the other (p=0.002, p=0.002, p=0.004, p=0.023 and p=0.0001). Also, IL6 was significantly correlated with insulin levels (p=0.0005). In a multivariate model, both insulin and LDL-cholesterol were independently associated with OPG, while only insulin was independently associated with IL6. Our results showed no effect of a short-term calcium-vitamin D treatment on circulating cytokines, CRP, insulin levels and lipid parameters. This could be related to the low circulating cytokine concentrations in healthy subjects or to the short duration of treatment. The interesting association we found between OPG and some cardiovascular risk markers deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669830     DOI: 10.1007/BF03347358

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Interleukin-6: the endocrine cytokine.

Authors:  D A Papanicolaou; A N Vgontzas
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

2.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

Authors:  P A Price; H H June; J R Buckley; M K Williamson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

Review 5.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Authors:  P Lips
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

6.  Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density.

Authors:  Süleyman Türk; Mehmet Akbulut; Alaattin Yildiz; Mehmet Gürbilek; Said Gönen; Zeki Tombul; Mehdi Yeksan
Journal:  Nephron       Date:  2002-02       Impact factor: 2.847

Review 7.  RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.

Authors:  Michael Schoppet; Klaus T Preissner; Lorenz C Hofbauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

Review 8.  Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'?

Authors:  B J Boucher
Journal:  Br J Nutr       Date:  1998-04       Impact factor: 3.718

9.  Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.

Authors:  L C Hofbauer; C R Dunstan; T C Spelsberg; B L Riggs; S Khosla
Journal:  Biochem Biophys Res Commun       Date:  1998-09-29       Impact factor: 3.575

10.  1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro.

Authors:  K Müller; N Odum; K Bendtzen
Journal:  Immunol Lett       Date:  1993-02       Impact factor: 3.685

View more
  32 in total

1.  Factors associated with inflammation markers, a cross-sectional analysis.

Authors:  Tess V Clendenen; Karen L Koenig; Alan A Arslan; Annekatrin Lukanova; Franco Berrino; Yian Gu; Goran Hallmans; Annika Idahl; Vittorio Krogh; Anna E Lokshin; Eva Lundin; Paola Muti; Adele Marrangoni; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

2.  Calcium supplementation does not affect CRP levels in postmenopausal women--a randomized controlled trial.

Authors:  A Grey; G Gamble; R Ames; A Horne; B Mason; I R Reid
Journal:  Osteoporos Int       Date:  2006-05-30       Impact factor: 4.507

3.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Shabnam Salekzamani; Abolhassan Shakeri Bavil; Hossein Mehralizadeh; Mohammad Asghari Jafarabadi; Aymaral Ghezel; Bahram Pourghassem Gargari
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

4.  Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults.

Authors:  Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Brian M Dixon; Erik D Schneider; Vanessa T Henriksen; Lindell K Weaver
Journal:  Eur J Appl Physiol       Date:  2013-01-06       Impact factor: 3.078

5.  Chronic stress causes neuroendocrine-immune disturbances without affecting renal vitamin D metabolism in rats.

Authors:  P Jiang; L Zhang; W Zhu; H Li; R Dang; M Tang
Journal:  J Endocrinol Invest       Date:  2014-10-16       Impact factor: 4.256

6.  Vitamin D inflammatory cytokines and coronary events: a comprehensive review.

Authors:  Yoav Arnson; Dganit Itzhaky; Morris Mosseri; Vivian Barak; Boaz Tzur; Nancy Agmon-Levin; Howard Amital
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Relationship between vitamin D and inflammatory markers in older individuals.

Authors:  Francesca De Vita; Fulvio Lauretani; Juergen Bauer; Ivan Bautmans; Michelle Shardell; Antonio Cherubini; Giuliana Bondi; Giovanni Zuliani; Stefania Bandinelli; Mario Pedrazzoni; Elisabetta Dall'Aglio; Gian Paolo Ceda; Marcello Maggio
Journal:  Age (Dordr)       Date:  2014-08-03

8.  Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.

Authors:  M Kyla Shea; Sarah L Booth; Joseph M Massaro; Paul F Jacques; Ralph B D'Agostino; Bess Dawson-Hughes; José M Ordovas; Christopher J O'Donnell; Sekar Kathiresan; John F Keaney; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am J Epidemiol       Date:  2007-11-15       Impact factor: 4.897

9.  C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial.

Authors:  M P Bjorkman; A J Sorva; R S Tilvis
Journal:  J Nutr Health Aging       Date:  2009-05       Impact factor: 4.075

10.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.